 Medgadget.com | Abbott announces XIENCE Xpedition launch CSL Recruitment Abbott has announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System has been awarded a CE Mark in Europe. The solution will be used to treat coronary artery disease and is designed to optimise acute performance, especially when it ... Abbott XIENCE Xpedition Coronary Drug Eluting Stent Now Available in Europe Abbott launches Xience Xpedition stent in Europe |
